Veterinary Medicines

OLVAC A+B Emulsione iniettabile per polli

Authorised
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Avian infectious bronchitis virus, strain NEV14, Inactivated
  • Avian infectious bronchitis virus, strain NEV24, Inactivated
Download as PDF

Product identification

Medicine name:
OLVAC A+B Emulsione iniettabile per polli
Active substance:
  • Newcastle disease virus, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
  • Avian infectious bronchitis virus, strain NEV14, Inactivated
  • Avian infectious bronchitis virus, strain NEV24, Inactivated
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Newcastle disease virus, Inactivated
    8.50
    log 10 50% embryo infective dose
    /
    0.50
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    7.50
    log 10 50% embryo infective dose
    /
    0.50
    Dose
  • Eggdrop syndrome-1976 virus, strain V127, Inactivated
    7.50
    log 10 50% embryo infective dose
    /
    0.50
    Dose
  • Avian infectious bronchitis virus, strain NEV14, Inactivated
    7.50
    log 10 50% embryo infective dose
    /
    0.50
    Dose
  • Avian infectious bronchitis virus, strain NEV24, Inactivated
    7.50
    log 10 50% embryo infective dose
    /
    0.50
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken (layer hen)
      • Meat and offal
        0
        day
    • Chicken (for reproduction)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 101816
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 15/12/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."